Johnson & Johnson's (JNJ) results show the firm's ability to offset generic and branded competition, says Damien Conover. He and David Toung recap JNJ's earnings. They talk about how the 4Q international sales came in at $11.19B and 4Q worldwide consumer sales came in at $3.77B. They then go over the key takeaways from JNJ's earnings. Tune in to find out more about the stock market today.
25 Jan 2023
Trading 360
18 Apr 2023
Next Gen Investing
18 Apr 2023
The Watch List
17 May 2023
Market On Close
23 May 2023
The Watch List
17 Apr 2023
Market On Close
28 Mar 2023